Lyfur-CV 625 Tablet
Marketer
Lichem Pharmaceuticals
Salt Composition
Cefuroxime (500mg) + Clavulanic Acid (125mg)
Overview Lyfur-CV 625 Tablet
Combiflox 625mg tablets combat diverse bacterial infections by hindering microbial proliferation and propagation. This prescription medication should be administered precisely as directed. Consumption with or without food is acceptable, but consistent timing is crucial for optimal effectiveness. Exceeding the prescribed dosage can be detrimental. Missed doses should be taken promptly upon recollection. Complete the prescribed course, even with symptom improvement; premature cessation may compromise efficacy. Common side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects warrant immediate medical attention. Seek immediate medical help for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your physician of all current medications, including those for pre-existing conditions. Pregnant or lactating individuals should consult their doctor before use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occurs. Adequate rest, a nutritious diet, and sufficient hydration are recommended for faster recovery. Your physician may order lab tests and diagnostic imaging to monitor the medication's effects.
Uses of Lyfur-CV 625 Tablet
Managing bacterial infections
Major Benefits of Lyfur-CV 625 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Lyfur-CV 625 Tablets. Ingest the tablets whole; avoid crushing, chewing, or breaking them. These tablets can be taken with or without food, but consistent timing is recommended.
Common Side effects of Lyfur-CV 625 Tablet:
- Nausea
- Vomiting
- Diarrhea
- Increased liver enzymes
- Allergic reaction
How to use Lyfur-CV 625 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Lyfur-CV 625 Tablets. These tablets should be swallowed whole; avoid chewing, crushing, or breaking them. While Lyfur-CV 625 Tablets can be administered with or without food, consistent timing is recommended for optimal results.
How Lyfur-CV 625 Tablet works:
Cefuroxime and Clavulanate potassium, combined as Lyfur-CV 625 Tablet, offer a dual-action approach to bacterial infection. Cefuroxime, an antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to thrive. Clavulanate potassium, a beta-lactamase inhibitor, counteracts bacterial enzymes that would otherwise neutralize Cefuroxime. This synergistic effect broadens the antibiotic's effectiveness and overcomes bacterial resistance mechanisms.
SAFETY ADVICE
AlcoholSAFE
Lyfur-CV 625 Tablet consumption alongside alcohol poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The use of Lyfur-CV 625 Tablets during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, research involving human subjects is scarce.
Breast feedingSAFE IF PRESCRIBED
Lactation and the use of Lyfur-CV 625 Tablets pose no known safety risk. Research in human subjects indicates minimal to negligible drug transfer into breast milk, posing no apparent threat to the infant.
DrivingNOT RELEVANT
Lyfur-CV 625 Tablet is exclusively for inpatient administration.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Lyfur-CV 625 Tablet's use in individuals with renal impairment. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Lyfur-CV 625 Tablet use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Lyfur-CV 625 Tablet :
Should you forget a Lyfur-CV 625 Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Lyfur-CV 625 Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |


